Overexpression of cyclin D1 in human esophageal carcinomas has been we
ll documented, The aim of the present study was to assess the expressi
on of cyclin D1 in different types of esophageal epithelial lesions in
duced by N-nitrosomethylbenzylamine (NMBA) in rats, A total of 30 rats
received s.c.-injections, five times/week, of 1.0 mg/kg NMBA for a pe
riod of 5 weeks followed by the same dose once per week for another 10
weeks, An additional 15 rats were given saline and used as controls t
o provide normal epithelium, The tumor incidence was 100% at the termi
nation point of 21 weeks. Seventeen rats (57%) showed nuclear staining
for cyclin D1, with a great variation in the intensity, as demonstrat
ed by using an immunohistochemical technique, The cyclin D1 positive i
ndices were in the range of 0% to 60% of the individual cells. Negligi
ble staining was observed for normal esophageal epithelium, with a min
imal increase in hyperplastic and dysplastic lesions. A significant el
evation of cyclin D1 levels was observed in tumors. However, no signif
icant differences were found between papillomas and carcinomas, The im
munohistochemical results were confirmed by western blotting analysis,
Tumors, papillomas and carcinomas overexpressing cyclin D1 had elevat
ed proliferating cell nuclear antigen (PCNA) indices (P <0.05). The co
rrelation coefficient of overexpressions of PCNA and cyclin D1 was r=0
.7 for papillomas, but only r=0.3 for carcinomas, The study thus provi
des strong evidence of relatively early overexpression of cyclin D1 du
ring tumorigenesis in the present rat esophageal model. Cyclin D1 expr
ession is not simply a direct consequence of increase cell proliferati
on.